Company
LON:AZN
AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease. AstraZeneca has over 67,000 empolyees and operates in over 100 countries with growing presence in important emerging markets.
1084 stories · page 44 of 55
“Our clear preference is for specialty-focus and growth in the context of a strong-catalyst driven thematic or deep value,” Barclays said in a brief note to clients.
The new once-daily medicine is to improve blood sugar level control in adults where single treatments of the drugs have proved inadequate.
Astrazeneca has offloaded the US and Canada commercial rights of Zoladex to focus on new oncology medicines.
We’ve had the final results from Holy Trinity of the UK pharma industry ... which is the one to back?
AstraZeneca said patients treated with Lynparza showed a statistically-significant and clinically-meaningful improvement in progression-free survival.
Investments and investor services
Around 3.15pm, the UK blue chip index was up over 21 points at 7,299, not far from the day’s peak of 7,307, and well above the day’s low of 7,253.
The main risers and fallers around 2.45pm included Metal Tiger, CloudTag, Laura Ashley ...
Investments and investor services
FTSE 100 shares closed lower, dragged down by weaker US stocks and a flurry of ex-dividend stocks in London
Investments and investor services
Shire’s results Thursday will update on how 2016 ended as it provides commentary and numbers on the fourth quarter, which will be consolidated to provide full-year numbers too.
Archive
Shire will complete the fourth-quarter results announcements from the FTSE 100-listed pharma giants following numbers from Astra and Glaxo
Archive
BP could please on Thursday as its recent quarterly updates have proved a little disappointing. GlaxoSmithKline will unveil its numbers Wednesday.
The important number for the mainly income-hunting investor base was the dividend, which was bumped up to US$2.80 a share – providing a chunky yield in excess of 5%.
Investments and investor services
The BoE said the UK economy will grow substantially faster than its downgraded forecasts made in the wake of last June's shock Brexit vote.
Archive
Vodafone, Astrazeneca and Vedanta are among the blue-chips due to report on Thursday.
The normally reliable investment strategy based on the "Dogs of the Dow" system has had a bad couple of years; what if we tweaked it?
Archive
The normally reliable investment strategy based on the "Dogs of the Dow" system has had a bad couple of years; what if we tweaked it?
Archive
Big names reporting this week: SSE, TalkTalk, AstraZeneca, Compass, Vedanta
FTSE 100 stocks fell further below 7200 on Monday after sterling gained strength against the US dollar in the aftermath of President Donald Trump's inauguration speech
It made the decision about the Opdivo and Yervoy combination after assessing the data available
